+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enteral Feeding Device Market - Forecasts from 2021 to 2026

  • PDF Icon

    Report

  • 114 Pages
  • July 2021
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5397998
The global enteral feeding devices market is evaluated at US$1,595.392 million for the year 2019 and is projected to grow at a CAGR of 4.94% to reach US$2,236.218 million by the year 2026. Enteral feeding refers to the delivery of nutrients or medications via medical devices directly into the digestive tract. Such devices are called enteral feeding devices and are used to supply nutrients to critically and bedridden patients, who cannot food on their own. The rising prevalence of gastrointestinal disorders, neurological disorders, and chronic diseases such as cancer is anticipated to propel the growth of the global enteral feeding devices market during the forecast period. The rising geriatric population and adoption of an unhealthy lifestyle are also major drivers for market growth in the coming years. The rising adoption of the enteral feeding tube as they cause fewer side effects and have fewer chances of infection when compared to the parenteral devices is also expected to drive the market growth. Furthermore, technological advancements in the development of enteral feeding products including texture modifications, the introduction of portable and affordable devices are also projected to boost the market growth of enteral feeding devices during the assessment period.



The recent outbreak of the novel coronavirus had a positive impact on the global enteral feeding devices market. The critically ill COVID-19 patients and the people already suffering from serious conditions who caught COVID-19 were given nutrition support via enteral feeding devices and hence the pandemic led to rising demand for enteral feeding devices. Organizations such as the European Society for Clinical Nutrition and Metabolism (ESPEN) had advised enteral nutrition for severe COVID-19 patients in ICU. This led to a surge in the growth of the global enteral feeding devices market during the pandemic. Although the COVID-19 induced growth is likely to reduce in the future, the global enteral feeding devices market is still projected to grow strong owing to the rising cases of chronic diseases.

The rise in prevalence of chronic diseases.

One of the major factors anticipated to drive the growth of the global enteral feeding devices market during the forecast period is the growing number of people with chronic diseases around the world, which is leading to an increased demand for enteral feeding devices. According to CDC, 60% of the population in the United States suffers from a chronic disease, while nearly 40% suffer from two or more. The prevalence of conditions such as heart diseases, cancer, chronic lung disease, stroke, Alzheimer's disease, diabetes, chronic kidney disease, and many other chronic diseases has been increasing over the years. A paper in the Journal of the American College of Cardiology stated in December 2020 that there were 270 million cases of cardiovascular diseases in 1990 which nearly doubled to 523 million in 2019. The Global Burden of Disease Study 2019 published in The Lancet medical journal shows that from 1990 to 2019 the rates of ischemic heart disease has gone up by 50%, diabetes by 148%, stroke by 32%, chronic kidney disease by 93%, and lung cancer by 69%.

Growing geriatric population.

As the prevalence of conditions requiring enteral feeding increases with age, the demand for enteral feeding devices is expected to surge with a rising number of elderly people around the world. According to the World Population Ageing 2019 report by the Department of Economic & Social Affairs, UN, around 6% of the population was aged 65 or above in 1990 which increased to 9% in 2019, and it is projected to increase to 16% by 2050. The number of people aged 65 years or above is projected to increase from 703 million in 2019 to 1.5 billion by 2050. Around 1 in 11 people around the world was over the age of 65 in 2019 and it is projected to increase to 1 in 6 people by 2050, as per the report. This projected rise in the geriatric population is anticipated to boost the growth of the global enteral feeding devices market during the forecast period.

North America to hold a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to the high prevalence of chronic diseases, especially in the United States, and the presence of an advanced healthcare system. Also, the high adoption rate and the research and development activities are some other factors projected to drive the market growth in the region. The Asia Pacific region is anticipated to witness substantial growth due to rising cases of chronic diseases such as cancer and cardiovascular diseases, especially in countries like China and India. In India, nearly 57% of the total deaths in the age group of 25–69 years were caused by cardiovascular diseases, as per the MCCD report 2018. The rise in the geriatric population in the region is also anticipated to propel market growth during the forecast period.

Market Segmentation:


By Type


  • Enteral Feeding Pumps
  • Enteral Feeding Tubes
  • Enteral Syringes
  • Others

By Age Group


  • Adult
  • Pediatric

By Application


  • Gastroenterology
  • Oncology
  • Neurology
  • Hypermetabolism
  • Diabetes
  • Others

By End-User


  • Hospitals
  • Home Care
  • Ambulatory Care Settings

By Geography


  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others
Frequently Asked Questions about the Enteral Feeding Device Market

What is the estimated value of the Enteral Feeding Device Market?

The Enteral Feeding Device Market was estimated to be valued at $1595.39 million in 2019.

What is the growth rate of the Enteral Feeding Device Market?

The growth rate of the Enteral Feeding Device Market is 4.9%, with an estimated value of $2236.22 million by 2026.

What is the forecasted size of the Enteral Feeding Device Market?

The Enteral Feeding Device Market is estimated to be worth $2236.22 million by 2026.

Who are the key companies in the Enteral Feeding Device Market?

Key companies in the Enteral Feeding Device Market include Boston Scientific Corporation, GBUK Enteral Ltd., Nestle SA, B.Braun Melsungen AG, Cardinal Health, Inc., Vygon (UK) Ltd, Avanos Medical, Inc., Rockfield Medical Devices and Fresenius SE & Co. KGaA.

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Enteral Feeding Devices Market Analysis, by Type
5.1. Introduction
5.2. Enteral Feeding Pumps
5.3. Enteral Feeding Tubes
5.4. Enteral Syringes
5.5. Others
6. Enteral Feeding Devices Market Analysis, by Age Group
6.1. Introduction
6.2. Adult
6.3. Pediatric
7. Enteral Feeding Devices Market Analysis, by Application
7.1. Introduction
7.2. Gastroenterology
7.3. Oncology
7.4. Neurology
7.5. Hypermetabolism
7.6. Diabetes
7.7. Others
8. Enteral Feeding Devices Market Analysis, by End-User
8.1. Introduction
8.2. Hospitals
8.3. Home Care
8.4. Ambulatory Care Settings
9. Enteral Feeding Devices Market Analysis, by Geography
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. UK
9.4.4. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Taiwan
9.6.6. Thailand
9.6.7. Indonesia
9.6.8. Others
10. Competitive Environment and Analysis
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix
11. Company Profiles
11.1. Boston Scientific Corporation
11.2. GBUK Enteral Ltd.
11.3. Nestle SA
11.4. B.Braun Melsungen AG
11.5. Cardinal Health, Inc.
11.6. Vygon (UK) Ltd
11.7. Avanos Medical, Inc.
11.8. Rockfield Medical Devices
11.9. Applied Medical Technology, Inc.
11.10. Fresenius SE & Co. KGaA
11.11. Danone S.A.
11.12. Conmed Corporation

Companies Mentioned

  • Boston Scientific Corporation
  • GBUK Enteral Ltd.
  • Nestle SA
  • B.Braun Melsungen AG
  • Cardinal Health, Inc.
  • Vygon (UK) Ltd
  • Avanos Medical, Inc.
  • Rockfield Medical Devices
  • Applied Medical Technology, Inc.
  • Fresenius SE & Co. KGaA
  • Danone S.A.
  • Conmed Corporation